Paul McBarron

Director of Finance/CFO presso CYCLACEL PHARMACEUTICALS, INC.

Patrimonio netto: 70 428 $ in data 31/03/2024

63 anni

Health Technology

Commercial Services

Posizioni attive di Paul McBarron

Società	Posizione	Inizio	Fine
CYCLACEL PHARMACEUTICALS, INC.	Director/Board Member	01/03/2006	-
	Chief Operating Officer	01/01/2002	-
	Director of Finance/CFO	01/01/2002	-
	Investor Relations Contact	-	-
	Public Communications Contact	-	-
	Corporate Secretary	01/01/2002	-
	Comptroller/Controller/Auditor	01/01/2002	-

Società	Posizione	Inizio	Fine
Cyclacel Group Plc Cyclacel Group Plc Pharmaceuticals: MajorHealth Technology Cyclacel Group Plc designs and develops small molecule drugs. The company developed small molecule drugs act on key cell cycle regulators to stop uncontrolled cell division in cancer and other diseases involving abnormal cell proliferation. Cyclacel Group Plc was founded by Professor Sir David Lane in 1996 and is headquartered in Dundee, UK.	Chief Operating Officer	01/01/2002	15/10/2008
	Corporate Secretary	01/01/2002	15/10/2008
SHIRE	Comptroller/Controller/Auditor	01/01/1996	01/01/2001
SHIRE	Director of Finance/CFO	01/01/1996	01/01/2001
Scottish Lifesciences Association Scottish Lifesciences Association Miscellaneous Commercial ServicesCommercial Services The Scottish Lifesciences Association operates an association for life sciences companies and organizations.	Director/Board Member	-	-

Distribuzione geografica

Posizioni

Chief Operating Officer	2
Corporate Secretary	2
Comptroller/Controller/Auditor	2

Settori

Health Technology	4
Commercial Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
CYCLACEL PHARMACEUTICALS, INC.	Health Technology

Aziende private	3
Cyclacel Group Plc Cyclacel Group Plc Pharmaceuticals: MajorHealth Technology Cyclacel Group Plc designs and develops small molecule drugs. The company developed small molecule drugs act on key cell cycle regulators to stop uncontrolled cell division in cancer and other diseases involving abnormal cell proliferation. Cyclacel Group Plc was founded by Professor Sir David Lane in 1996 and is headquartered in Dundee, UK.	Health Technology
Shire Plc Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland.	Health Technology
Scottish Lifesciences Association Scottish Lifesciences Association Miscellaneous Commercial ServicesCommercial Services The Scottish Lifesciences Association operates an association for life sciences companies and organizations.	Commercial Services